Ortho-alkynyl anilines and process for preparation thereof

US9758476B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9758476-B2
Application numberUS-201515321329-A
CountryUS
Kind codeB2
Filing dateJun 22, 2015
Priority dateJun 25, 2014
Publication dateSep 12, 2017
Grant dateSep 12, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to novel ortho alkynyl anilines of formula (I) which are useful in synthesis of drug intermediates and natural products and process for preparation of these ortho alkynyl anilines of formula (I) via copper catalyzed Multi Component Reactions (MCR).

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of formula (I) wherein, R 1 is selected from hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, and ester; R 2 is selected from hydrogen, substituted or unsubstituted alkyl(C 1 to C 7 ), and substituted or unsubstituted aryl; R 3 is selected from hydrogen, substituted or unsubstituted alkyl(C 1 to C 7 ), substituted or unsubstituted aryl, and alkoxy; R 4 is selected from hydrogen, substituted or unsubstituted C 1 to C 7 alkyl, substituted or unsubstituted aryl, and alkoxy; and R 3 and R 4 jointly represent 1,3-dioxolyl. 2. The compound as claimed in claim 1 , wherein said compound of formula (I) are selected from the group consisting of: i. Dibenzyl1-(2-(3-ethoxy-3-oxoprop-1-yn-1-yl)phenyl)hydrazine-1,2-dicarboxylate; ii. Dibenzyl1-(2-(3-ethoxy-3-oxoprop-1-yn-1-yl)-4,5-dimethoxyphenyl)hydrazine-1,2-dicarboxylate, iii. Dibenzyl1-(6-(3-ethoxy-3-oxoprop-1-yn-1-yl)benzo[d][1,3]dioxol-5-yl)hydrazine-1,2-dicarboxylate and iv. Dibenzyl1-(2-(3-ethoxy-3-oxoprop-1-yn-1-yl)-4,5-dimethylphenyl) hydrazine-1,2-dicarboxylate. 3. A one-pot process for the preparation of a compound of formula (I) comprising the steps of: i. stirring a reaction mixture of (trimethylsilyl) aryl triflates with terminal alkyne and azodicarboxylate in the presence of a copper catalyst, cesium fluoride and solvent at a temperature in the range of 80 to 110° C. for a period ranging from 8 to 15 h to obtain a mixture; ii. cooling the mixture as obtained in step (i) at room temperature in the range of 20 to 30° C. followed by filtering and purifying to obtain compound of formula (I), wherein the compound of formula (I) is: wherein, R 1 is selected from hydrogen, substituted or unsubstituted alkyl, substituted or unsubstituted aryl, and ester; R 2 is selected from hydrogen, substituted or unsubstituted alkyl(C 1 to C 7 ), and substituted or unsubstituted aryl; R 3 is selected from hydrogen, substituted or unsubstituted alkyl(C 1 to C 7 ), substituted or unsubstituted aryl, and alkoxy; R 4 is selected from hydrogen, substituted or unsubstituted C 1 to C 7 alkyl, substituted or unsubstituted aryl, and alkoxy; and R 3 and R 4 jointly represent 1,3-dioxolyl. 4. The process as claimed in claim 3 , wherein said copper catalyst is a copper (I) salt selected from the group consisting of copper chloride, copper bromide, and copper iodide. 5. The process as claimed in claim 3 , wherein the (trimethylsilyl) aryl triflates are selected from the group consisting of 2-(trimethylsilyl)phenyl trifluoromethanesulfonate, 4,5-dimethoxy-2-(trimethylsilyl)phenyl trifluoromethanesulfonate, 6-(trimethylsilyl)benzo[d][1,3]dioxol-5-yl trifluoromethane-sulfonate, 4,5-dimethyl-2-(trimethylsilyl)phenyl trifluoromethanesulfonate. 6. The process as claimed in claim 3 , wherein the terminal alkyne is selected from the group consisting of ethyl propiolate, methyl propiolate and butyl propiolate. 7. The process as claimed in claim 3 , wherein said azodicarboxylate is selected from dibenzyl azodicarboxylate and dialkyl azodicarboxylate. 8. The process as claimed in claim 3 , wherein said solvent is selected from the group consisting of dichloromethane, tetrahydrofuran, ethyl acetate, toluene, acetonitrile, and dimethylformamide.

Assignees

Inventors

Classifications

  • C07C281/02Primary

    Compounds containing any of the groups [IMAGE cpc-sch-C07C-0972.gif], e.g. carbazates · CPC title

  • Nitrogen atoms not forming part of a nitro radical · CPC title

  • only one oxygen atom which is attached in position 2 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9758476B2 cover?
The present invention relates to novel ortho alkynyl anilines of formula (I) which are useful in synthesis of drug intermediates and natural products and process for preparation of these ortho alkynyl anilines of formula (I) via copper catalyzed Multi Component Reactions (MCR).
Who is the assignee on this patent?
Council Scient Ind Res
What technology area does this patent fall under?
Primary CPC classification C07C281/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).